vs
Profound Medical Corp.（PROF）与VerifyMe, Inc.（VRME）财务数据对比。点击上方公司名可切换其他公司
Profound Medical Corp.的季度营收约是VerifyMe, Inc.的1.2倍（$6.0M vs $5.0M），VerifyMe, Inc.净利率更高（-66.7% vs -136.8%，领先70.1%）
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
VerifyMe, Inc.是一家专注于身份核验、防伪溯源及品牌保护服务的科技企业，为消费品、制药、零售等行业客户提供安全认证工具、全链路溯源系统与用户互动解决方案，业务覆盖北美及多个海外市场。
PROF vs VRME — 直观对比
营收规模更大
PROF
是对方的1.2倍
$5.0M
净利率更高
VRME
高出70.1%
-136.8%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.0M | $5.0M |
| 净利润 | $-8.2M | $-3.4M |
| 毛利率 | 66.8% | 41.2% |
| 营业利润率 | -123.3% | -68.2% |
| 净利率 | -136.8% | -66.7% |
| 营收同比 | — | -7.4% |
| 净利润同比 | — | -38.4% |
| 每股收益（稀释后） | $0.27 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PROFVRME
| Q4 25 | $6.0M | — | ||
| Q3 25 | $5.1M | $5.0M | ||
| Q2 25 | $2.0M | $4.5M | ||
| Q1 25 | $2.3M | $4.5M | ||
| Q3 24 | — | $5.4M | ||
| Q2 24 | — | $5.4M | ||
| Q1 24 | — | $5.8M | ||
| Q4 23 | — | $8.7M |
净利润PROFVRME
| Q4 25 | $-8.2M | — | ||
| Q3 25 | $-8.0M | $-3.4M | ||
| Q2 25 | $-15.7M | $-291.0K | ||
| Q1 25 | $-10.7M | $-571.0K | ||
| Q3 24 | — | $-2.4M | ||
| Q2 24 | — | $-346.0K | ||
| Q1 24 | — | $-553.0K | ||
| Q4 23 | — | $2.0K |
毛利率PROFVRME
| Q4 25 | 66.8% | — | ||
| Q3 25 | 77.7% | 41.2% | ||
| Q2 25 | 81.7% | 35.2% | ||
| Q1 25 | 79.2% | 33.4% | ||
| Q3 24 | — | 34.9% | ||
| Q2 24 | — | 39.1% | ||
| Q1 24 | — | 39.2% | ||
| Q4 23 | — | 33.0% |
营业利润率PROFVRME
| Q4 25 | -123.3% | — | ||
| Q3 25 | -176.2% | -68.2% | ||
| Q2 25 | -696.9% | -7.1% | ||
| Q1 25 | -477.0% | -13.3% | ||
| Q3 24 | — | -52.8% | ||
| Q2 24 | — | -10.0% | ||
| Q1 24 | — | -11.2% | ||
| Q4 23 | — | 0.8% |
净利率PROFVRME
| Q4 25 | -136.8% | — | ||
| Q3 25 | -157.7% | -66.7% | ||
| Q2 25 | -792.3% | -6.4% | ||
| Q1 25 | -458.1% | -12.8% | ||
| Q3 24 | — | -44.6% | ||
| Q2 24 | — | -6.5% | ||
| Q1 24 | — | -9.6% | ||
| Q4 23 | — | 0.0% |
每股收益（稀释后）PROFVRME
| Q4 25 | $0.27 | — | ||
| Q3 25 | $0.26 | $-0.26 | ||
| Q2 25 | $0.52 | $-0.02 | ||
| Q1 25 | $0.36 | $-0.05 | ||
| Q3 24 | — | $-0.23 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | — | $-0.05 | ||
| Q4 23 | — | $0.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $59.7M | — |
| 总债务越低越好 | $4.5M | — |
| 股东权益账面价值 | $66.4M | $11.1M |
| 总资产 | $77.5M | $13.3M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资PROFVRME
| Q4 25 | $59.7M | — | ||
| Q3 25 | $24.8M | — | ||
| Q2 25 | $35.2M | — | ||
| Q1 25 | $46.4M | — | ||
| Q3 24 | — | $2.6M | ||
| Q2 24 | — | $2.9M | ||
| Q1 24 | — | $2.8M | ||
| Q4 23 | — | $3.0M |
总债务PROFVRME
| Q4 25 | $4.5M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $4.5M | — | ||
| Q3 24 | — | $500.0K | ||
| Q2 24 | — | $600.0K | ||
| Q1 24 | — | $800.0K | ||
| Q4 23 | — | $875.0K |
股东权益PROFVRME
| Q4 25 | $66.4M | — | ||
| Q3 25 | $32.1M | $11.1M | ||
| Q2 25 | $39.3M | $14.4M | ||
| Q1 25 | $50.8M | $14.6M | ||
| Q3 24 | — | $10.3M | ||
| Q2 24 | — | $12.3M | ||
| Q1 24 | — | $12.4M | ||
| Q4 23 | — | — |
总资产PROFVRME
| Q4 25 | $77.5M | — | ||
| Q3 25 | $42.3M | $13.3M | ||
| Q2 25 | $49.7M | $17.2M | ||
| Q1 25 | $60.9M | $17.1M | ||
| Q3 24 | — | $14.8M | ||
| Q2 24 | — | $17.5M | ||
| Q1 24 | — | $17.9M | ||
| Q4 23 | — | $20.7M |
负债/权益比PROFVRME
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.09× | — | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.05× | ||
| Q1 24 | — | 0.06× | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $243.0K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PROFVRME
| Q4 25 | $-6.6M | — | ||
| Q3 25 | $-9.6M | $243.0K | ||
| Q2 25 | $-13.7M | $710.0K | ||
| Q1 25 | $-8.3M | $-404.0K | ||
| Q3 24 | — | $-10.0K | ||
| Q2 24 | — | $372.0K | ||
| Q1 24 | — | $-60.0K | ||
| Q4 23 | — | $843.0K |
自由现金流PROFVRME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $-12.0K | ||
| Q2 24 | — | $369.0K | ||
| Q1 24 | — | $-62.0K | ||
| Q4 23 | — | $840.0K |
自由现金流率PROFVRME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | -0.2% | ||
| Q2 24 | — | 6.9% | ||
| Q1 24 | — | -1.1% | ||
| Q4 23 | — | 9.6% |
资本支出强度PROFVRME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.0% | ||
| Q4 23 | — | 0.0% |
现金转化率PROFVRME
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 421.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PROF
暂无分部数据
VRME
| Proactive Services | $4.2M | 83% |
| Other | $869.0K | 17% |
